The chemical class of "C14orf115 Inhibitors" consists of a diverse array of compounds that indirectly modulate the activity of the protein encoded by the C14orf115 gene. These inhibitors operate through a variety of mechanisms, impacting different cellular processes and signaling pathways interconnected with the protein's function. The diversity of this class highlights the complexity of protein regulation in cellular environments, where indirect modulation through influencing related pathways can significantly impact protein functions.
Compounds like Bortezomib and Sirolimus in this class demonstrate the impact of altering specific cellular enzymes and pathways on protein activity. Bortezomib, a proteasome inhibitor, affects the protein degradation pathways, which can lead to changes in protein levels within the cell, thereby indirectly influencing the activity of C14orf115. Sirolimus, known for its role in mTOR pathway modulation, illustrates how targeting cell growth and proliferation pathways can indirectly influence protein function.
Immunomodulatory agents such as Tacrolimus and Azathioprine exemplify how modifying the immune response can influence proteins involved in diverse cellular processes. Tacrolimus, through its inhibition of calcineurin, and Azathioprine, by modulating purine synthesis, showcase the interconnected nature of immune signaling and protein regulation. These compounds illustrate the potential of targeting immune responses to indirectly regulate proteins involved in various cellular functions.
Kinase inhibitors such as Sunitinib, by targeting various signaling pathways, offer insights into the broad effects of these inhibitors on cellular functions. Their ability to influence multiple pathways simultaneously demonstrates the potential for cascading impacts on proteins like C14orf115.
Moreover, compounds like Curcumin, Metformin, and Niacinamide, known for their roles in modulating inflammatory pathways, metabolic regulation, and NAD+ metabolism respectively, further highlight the wide-ranging methods through which cellular pathways can be targeted to influence protein activity. Curcumin's anti-inflammatory and antioxidant properties, Metformin's influence on glucose metabolism and AMPK pathways, and Niacinamide's role in NAD+ metabolism elucidate the varied approaches that can be employed to modulate protein function indirectly.
In summary, the "C14orf115 Inhibitors" class represents a strategic and comprehensive approach to protein modulation, emphasizing the potential of leveraging various biochemical pathways and cellular processes. This class not only sheds light on the complex regulation of proteins like C14orf115 but also underscores the broader implications of such modulation in cellular physiology. As research in this area progresses, a deeper understanding of these biochemical interactions is expected to emerge, offering new perspectives on protein regulation. This approach exemplifies the sophistication of current scientific understanding and the ongoing efforts to develop more effective strategies for modulating protein activity in complex biological systems.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Sirolimus, similar to Rapamycin, can affect mTOR signaling, potentially influencing C14orf115 activity. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Hydroxychloroquine, used in autoimmune diseases, can modulate immune responses, potentially influencing C14orf115 activity. | ||||||
Azathioprine | 446-86-6 | sc-210853D sc-210853 sc-210853A sc-210853B sc-210853C | 500 mg 1 g 2 g 5 g 10 g | $203.00 $176.00 $349.00 $505.00 $704.00 | 1 | |
Azathioprine, an immunosuppressive drug, can modulate purine synthesis, potentially affecting C14orf115 activity. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
Tacrolimus, an immunosuppressant, can inhibit calcineurin, potentially affecting C14orf115 activity through T-cell function modulation. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Niacinamide, a form of vitamin B3, can influence NAD+ metabolism, potentially affecting C14orf115 activity. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
Sunitinib, a tyrosine kinase inhibitor, can affect various signaling pathways, potentially influencing C14orf115 activity. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate, a dihydrofolate reductase inhibitor, can affect folate metabolism, potentially influencing C14orf115 activity. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone, a glucocorticoid, can influence gene expression and immune responses, potentially affecting C14orf115 activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, found in turmeric, can modulate inflammatory pathways and oxidative stress, potentially influencing C14orf115 activity. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib, a proteasome inhibitor, can affect protein degradation pathways, potentially influencing C14orf115 activity. | ||||||